Dental breakthrough: growth factor membranes may boost implant success in thin jaws

NCT ID NCT07534787

Not yet recruiting Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a dental procedure for people with narrow jawbones who need implants. Surgeons split the ridge, place the implant, and cover it with a membrane made from the patient's own blood (concentrated growth factor) to help healing. Ten adults aged 20-50 will be followed to measure pain and bone changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Concentrated Growth Factor (CGF) membranes
What this could lead to: If successful, this approach could improve dental implant success in patients with narrow jawbones, reducing pain and enhancing healing.
What could go wrong: This is a very small, early case series with only 10 participants, so results may not apply widely. Risks include infection, implant failure, or inadequate bone healing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CGF CONCENTRATED GROWTH FACTOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CGF CONCENTRATED GROWTH FACTOR IMPLANT PLACEMENT NARROW ALVEOLAR RIDGE POSTOPERATIVE PAIN

Dental breakthrough: growth factor membranes may boost implant success in thin jaws

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions